Chinese regulators – what’s going on?

The ongoing regulatory rollout by the Chinese central government to address equality amongst its citizens, has led to volatility in equity markets. This volatility has brought about questions regarding the long term direction of the Chinese economy and its impact on listed companies in our portfolios. In this Q&A session between Jonathan Wu (Chief Investment Specialist) and Derek Paas (Asia Investment Specialist), we will provide you an opportunity to ask questions and more importantly understand the context of the new regulatory environment in China to generate sustainable economic growth going forward.

Presented by Jonathan Wu and Derek Paas

This presentation is not financial product advice and is intended to provide information only. It does not take into account the investment objectives, financial situation or needs of any person. You should assess whether the information is appropriate for you and consider talking to a financial adviser before making an investment decision.
The information is taken from sources which are believed to be accurate but Premium China Funds Management accepts no liability of any kind to any person who relies on the information contained in the presentation.
Past performance is no indication of future performance. Unless expressly stated none of the information should be taken to be a recommendation.
Information in this presentation is believed to be accurate as at 1 June 2021.
Premium China Funds Management is the trading name of Premium China Funds Management Pty Ltd ABN 98 113 856 214, ACN 113 856 214, Australian Financial Services Licence No. 291570.
Equity Trustees Limited ABN 46 004 031 298 is the issuer of units in the Premium China Fund, Premium Asia Fund and Premium Asia Income Fund.
The rating contained in this document is issued by SQM Research Pty Ltd ABN 93 122 592 036. SQM Research is an investment research firm that undertakes research on investment products exclusively for its wholesale clients, utilising a proprietary review and star rating system. The SQM Research star rating system is of a general nature and does not take into account the particular circumstances or needs of any specific person. The rating may be subject to change at any time.
Only licensed financial advisers may use the SQM Research star rating system in determining whether an investment is appropriate to a person’s particular circumstances or needs. You should read the product disclosure statement and consult a licensed financial adviser before making an investment decision in relation to this investment product. SQM Research receives a fee from the Fund Manager for the research and rating of the managed investment scheme.
Investors should consider the Product Disclosure Statement (PDS) and Target Market Determination (TMD) relating to each Fund in deciding whether to acquire or continue to hold units in the Fund. The PDS and TMD are available from www.premiumchinafunds.com.au.